Chromosomal translocations t(4;11) are regularly associated with a speci®c type of acute leukemias and probably initiate the development of this disease. It has been proposed by others, that these translocations are mediated by recombinases of the immune system. The breakpoints on both derivative chromosomes for three t(4;11) leukemia-derived cell lines and primary blasts from two patients have been analysed here in detail. The results revealed that: (a) multiple double-or singlestranded DNA breaks must have occured near the translocation breakpoints on both participating chromosomes; and (b) DNA fragments¯anked by these breaks must have either been deleted, inverted or duplicated during the translocation process. We found no evidence for the involvement of speci®c target sequences and recombinases of the immune system. Similar characteristic features were observed by re-interpretation of published t(6;11) and t(9;22) translocation data. Therefore we present a new model for the generation of these translocations which poses, that these translocations are reciprocal but not balanced at the ®ne structure level and that the DNA damage-repair machinery is likely involved in producing the ®nal structure of the translocation breakpoint.
Introduction
Translocations to the ALL-1/MLL/HRX gene (Ziemin van der Poel et al., 1991; Djabali et al., 1992 ; Gu et al., 1992a; Tkachuk et al., 1992) are assumed to be the initial step of the malignant transformation of hematopoietic precursor cells generating certain types of acute myeloid and lymphoblastic leukemias (AML and ALL). Approximately 30 dierent chromosomal translocations to the 11q23 region of human chromosome 11 associated with hematologic neoplasias have so far been identi®ed, and at least one third of these are translocations to the ALL-1 gene located in the center of this region Marschalek et al., 1997) . Thus, apparently this gene is particularly promiscuous, and it became important to ask, which molecular mechanisms underly these translocations. Knowledge of the mechanisms leading to these translocations may permit identi®cation of individuals at risk and ultimately lead to the design of preventive measures.
One of the most frequent aberrations of the ALL-1 gene is the translocation t(4;11), which is found in early childhood leukemias with very poor prognosis (Cimino et al., 1993; Greil et al., 1994; Hunger et al., 1993; Iida et al., 1992; Kaneko et al., 1986; Katz et al., 1988; Lange et al., 1987; Pui et al., 1987 Pui et al., , 1990a Pui et al., , 1991a . Other authors have previously investigated the sequence of the chromosomal breakpoint on the derivative 11 chromosome (der11), one of the two derivative chromosomes generated by the reciprocal t(4;11) translocation, and concluded, that recombinases of the immune system may have caused the translocation (Gu et al., 1992b) . While it is true that recombinases of the immune system generate some oncogenic translocations as accidents of the rearrangement of lymphocyte antigen receptor genes, in those cases one of the two translocation partner genes typically was an antigen receptor gene (Hartl and Lipp, 1987) . In addition, in those cases speci®c target sequences for the recombinases of the immune system were usually found at the translocation breakpoint. None of these two characteristic signs were found for the t(4;11) translocation (Marschalek et al., 1995) . Therefore we questioned, whether recombinases of the immune system were involved in t(4;11) translocations and consequently have performed a more detailed investigation of t(4;11) translocation breakpoints in order to obtain further clues about the recombination mechanism.
Two recent improvements provided additional information about the ®ne structure of t(4;11) translocation breakpoints. One was the access to two novel leukemia-derived cell lines carrying a t(4;11) translocation, the SEM (Greil et al., 1994; Marschalek et al., 1995) and LLM lines (Greil et al., manuscript in preparation) , and the primary biopsy material from two children treated at our university hospital for t(4;11) leukemias. The other was the improved knowledge of the sequence of the breakpoint regions in both the parental ALL-1 and AF-4 genes, gathered by our group and others over the past few years Nilson et al., 1996 Nilson et al., , 1997 Rasio et al., 1996) . Previous studies (Gu et al., 1992b; Marschalek et al., 1995) were hampered by the fact, that in most cases they only had access to the sequence of the breakpoint on one of the two derivative chromosomes, the der11 chromosome carrying the centromere from chromosome 11 and the telomere from chromosome 4. The breakpoint on the der4 chromosome usually remained elusive, because the corresponding sequence from the intact AF-4 gene was unknown. In the past few years, the breakpoint cluster region (bpr) of the ALL-1 gene was mapped in an 8.3 kb fragment including introns 9, 10 and 11, and an 11 kb fragment encompassing this region has been sequenced. The sequence was deposited in public databases Marschalek et al., 1995; see Material and methods) . Similarly, the breakpoint cluster region of the AF-4 gene was mapped between exons 3 and 7 and only the small exons 4 (45 bp), 5 (87 bp) and 6 (37 bp) were found inside this region (Chen et al., 1993; Nilson et al., 1997) . In the course of the present study, approximately half of the breakpoint region of the AF-4 gene has been sequenced. This new information allowed the design of oligonucleotides from the breakpoint regions of both the AF-4 and ALL-1 genes and their use in polymerase chain reaction (PCR) experiments to amplify and sequence the breakpoints from genomic DNA of leukemic cells.
Genomic breakpoint sequences for both derivative chromosomes had previously been published for only one t(4;11) cell line, the RS4;11 line (Gu et al., 1992b) and breakpoint sequences for the der4 chromosome have been reported for the MV4;11 and SEM lines (Gu et al., 1992b; Marschalek et al., 1995) . The combined recent information allowed the re®ned mapping of the breakpoints on both derivative chromosomes for all three lines investigated here and for primary patient material. The data point to a mechanism of translocation clearly distinct from the rearrangement of antigen receptor genes and from other known mammalian recombination mechanisms.
Results
The breakpoint cluster region of the human AF-4 gene is located between exons 3 and 7
To map and further characterize the breakpoint cluster region of the parental AF-4 gene, a genomic DNA library prepared with DNA from SEM cells was screened both with a cloned AF-4 genomic DNA probe and a cDNA probe representing exons 4 and 5, that were available from previous studies . As a result, clones containing two large BamHI and two large EcoRI fragments were isolated. The inserts were recovered, subcloned and mapped using the restriction endonucleases BamHI, EcoRI and HindIII. The map order of the resulting fragments was established by virtue of their overlaps and by comparison of their sequences with the known cDNA sequence (Chen et al., 1993;  Figure 1 ). These four large DNA fragments were partially sequenced, and the combined total of their presently available sequences is approximately 25 kb. The region between exons 3 and 7 has been estimated by others to be at least 38 kb in length (Chen et al., 1993) . The map presented here still contains a gap of at least 10 kb (Figure 1 ). The location of the breakpoints for three of the four cell lines investigated here (SEM, S; RS4;11, R; and MV4;11, M) and for one of the primary patient samples (CB), established as described below, is indicated in Figure 1 .
Isolation of breakpoint amplimers for three t(4;11) cell lines
Six mixed pairs of oligonucleotide primers consisting of one primer from each of the ALL-1 and AF-4 genes (Materials and methods) were used to amplify chromosomal breakpoint segments from genomic DNA prepared from the t(4;11) lines. All amplimers spanning the breakpoints were analysed by gel electrophoresis, cloned and sequenced (Figure 2 ). The sequence data con®rmed the published breakpoints for both derivative chromosomes of the RS4;11 line (Gu et al., 1992b) and the breakpoint for the der4 chromosome of the SEM cell line (Marschalek et al., 1995) , thus establishing the validity of our technique. The published data for the RS 4;11 line included only approximately 60 nucleotides around the breakpoint on each derivative chromosome, but the location of these sequences within the ALL-1 and AF-4 genes A restriction map is shown for both break-point cluster regions. B, E, H: restriction cleavage sites for the enzymes BamHI, EcoRI and HindIII. Sizes (kb) refer to genomic BamHI fragments. Breakpoints of the t(4;11) lines SEM (S), RS4;11 (R), MV4;11 (M) and from patient (CB) were analysed as described in the text Figure 2 Structure of chimeric breakpoint fragments generated by genomic PCR. (Left side) Agarose gels. PCR amplimers were generated with genomic DNA from each cell line. PCR reactions were performed using allele-speci®c sets of oligonucleotides for the wt11, der11, der4 and wt4 chromosomes, respectively. Marker: lambda phage DNA digested with ClaI. Sizes in basepairs. (Right side) schematic representation of all four alleles ampli®ed for each of lines MV4;11, SEM and RS4;11. Blank bars and boxes: introns and exons of the ALL-1 gene. Dark bars and boxes: introns and exons of the AF-4 gene; (exon numbers according to Marschalek et al., 1997; Nilson et al., 1996 Nilson et al., , 1997 . Hatched areas: genomic portions which were either duplicated (MV4;11), deleted (SEM) or inverted (RS4;11). Blank and black triangles: oligonucleotides speci®c for the ALL-1 and AF-4 genes, respectively. Primer sets used for the ampli®cation process are given in small letters. Asterisk: presumably non-speci®c primer dimers. 1 kb-scale: applicable to all schemes remained unknown. The data reported here connect these sequences with the newly established sequences of the breakpoint regions of both the ALL-1 and AF-4 genes. Unexpectedly, our data for the MV4;11 line diered from the published data (Gu et al., 1992b) . Oligonucleotides AF4 I.3 and I9.52 generated a 3.1 kb PCR amplimer as opposed to a 655 bp amplimer expected from published data. The 3.1 kb amplimer was cloned and sequenced and the actual breakpoint was located 2 475 bp to the telomeric side of the published breakpoint on chromosome 4 and 33 bp to the centromeric side of the published breakpoint on chromosome 11. The integrity of our 3.1 kb amplimer was con®rmed by a second genomic PCR experiment, using a dierent pair of primers (AF4 I.31 and I9.52) that ampli®ed a shorter der4 breakpoint fragment of approximately 760 bp (Figure 2 ). This amplimer was also sequenced, and the sequence con®rmed the conclusions drawn from the ®rst experiment. This information allowed us to design a new primer pair (I9.3 and AF4.51) and to amplify and sequence a der11 breakpoint fragment of approximately 2.4 kb from MV4;11 cells ( Figure 2) .
Similarly, the new information about the breakpoint cluster region of the AF-4 gene allowed us to amplify and sequence all six parental ALL-1 and AF-4 alleles in the vicinity of the breakpoints as well as the three der11 and the three der4 breakpoints derived from these three t(4;11) lines. The sequences ( Figure 3 ) were deposited in public databases (Genbank accession numbers Y16596 to Y16609). Data for a fourth t(4;11) line, the LLM line, have also been obtained, but must await a more complete account of the origin and properties of this line (Greil et al., manuscript in preparation) before they can be deposited in the databases.
Implications for the recombination mechanism derived from the ®ne structure of the breakpoints
The ®ne structure of the breakpoints determined here pointed to the unexpected fact, that none of these translocations were balanced in the conventional sense meaning that no DNA sequences had been gained or lost. All breakpoints showed duplications, deletions and inversions of short DNA fragments (Figure 3 ). From these sequences we attempted to reconstruct the most plausible translocation pathway by manual and visual sequence comparison and alignment ( Figure 3 ). Our interpretation suggests the following:
For MV4;11 cells we propose, that two single-strand DNA breaks (thin arrows in Figure 3 ) have occurred in the DNA backbone of chromosome 4 (Figure 3a) . The staggered break must have created long 5'-overhangs. After strand separation and fusion to fragments from chromosome 11, the missing nucleotides were ®lled in by a polymerase creating the observed duplicated segment of 249 bp (Figure 3a) . For chromosome 11 the data point to a simple double-strand DNA break (thick arrow in Figure 3 ).
For SEM cells the deletion of two small DNA fragments can best be explained by six single-strand and two double-strand DNA breaks. The two resulting fragments B (381 bp) and F (316 bp) most likely were lost in the subsequent repair process with the exception of the short single-strand fragment d derived from (Figure 3b ). The short fragment d probably was used as a so-called`®ller' fragment. Filler fragments are short oligomeric DNA molecules that can be captured during DNA repair processes in mammalian cells (Roth et al., 1991) . In addition, the presence of fragment d provides an explanation for the presence of the additional guanyl residue found inserted between fragments E and C in the der4 chromosome of SEM cells. The generation of the der11 chromosome can best be explained by a simple blunt-end ligation of fragments A and G (Figure 3) .
Four single-strand and two double-strand DNA breaks can explain the deletion of fragment E and the inversion of fragment B in RS4;11 cells. Four singlestrand breaks in chromosome 11 created fragment B with overhanging nucleotides on both sides (Figure 3c ). These overhangs probably annealed with single strand overhangs from the broken chromosome 11, and thus fragment B may have been captured in an inverted orientation ( Figure 3c ). The 8 bp fragment E has no apparent ability to interact with any of the other DNA fragments and therefore may have been lost in the process, while fragments A and F were ligated to create the der11 chromosome.
The breakpoint on the der11 chromosome of a novel t(4;11) cell line, established from a 6 month old child and designated LLM (Greil et al., manuscript in preparation) , has also been analysed and the result was very similar to that observed for the RS4;11 line ( Figure 3c ). An inversion of a 47 bp fragment from chromosome 11 at the boundary between intron 8 and exon 9 destroyed the splice acceptor site of exon 9. Until now we were unable to isolate and sequence the breakpoint on the der4 chromosome of this line.
t(4;11) chromosomal breakpoints in primary biopsy material suggest a similar mechanism of translocation Breakpoint fragments from both derivative chromosomes of patient CB carrying a t(4;11) translocation (Materials and methods) were isolated from primary biopsy material and analysed. The breakpoints were mapped to intron 11 of the ALL-1 gene (approximately 1.4 kb downstream of exon 11) and to intron 3 of the AF-4 gene (approx. 3 kb to the 3' side of exon 3). The breakpoint fragments from both derivative chromosomes were cloned and sequenced. A 75 bp duplication of wildtype ALL-1 sequences and a 119 bp duplication of wildtype AF-4 sequences were observed (Figure 3d,  Figure 4) . Thus, the ®ne structure of the translocation breakpoint in these primary leukemic blasts showed very similar characteristic features as those observed for the MV4;11 line (Figure 3a) .
To address the question, whether breakpoints remained stable in leukemia-derived cell lines or showed further rearrangements during prolonged expansion of such blasts in culture, the con®guration of the breakpoint in the SEM line was compared with its status in primary blasts from the same patient that had been cryopreserved at relapse (Greil et al., 1994) . Identical PCR amplimers were obtained with DNA from both sources (Figure 5 ), indicating that the breakpoint had remained stable over several years of continuous culture. All eight PCR products visible in Figure 5 were cloned and sequenced and the sequences were identical for DNA from both sources. Tumorderived cell-lines are known to exhibit genomic instability. This instability may also exist for the SEM line with respect to its entire genome. However, our data indicate that the instability, if it existed for this line, was not suciently extensive to manifest itself by subsequent rearrangements of the same site over a period of several years in continuous culture, which was estimated to be equivalent to more than one hundred cell generations.
Published cases of t(6;11) and t(9;22) translocations (Ph') can also be explained by the damage-repair model
The chromosomal breakpoint of a patient with a therapy-related AML and translocation t(6;11) can be interpreted in a similar manner (Figure 6 ; Strout et al., 1996) . Severe DNA damage probably occurred as a consequence of the chemotherapeutic treatment. Chromosome 11 may have undergone as many as 12 single-strand and one double-strand break, while chromosome 6 probably suered only a single 5'-staggered break. We postulate that at least 10 dierent fragments (A ± J) were generated and recovered during the repair process. This scheme would provide an explanation for the presence of a 186 nucleotide fragment from chromosome 11 in the der6 chromosome ( Figure 6 , fragment d) and for its complementary sequence in the inverted orientation in the der11 chromosome ( Figure 6 , fragment d'). It would further provide an explanation for the presence of the two Figure 4 Duplication of ALL-1 and AF-4 sequences at the genomic fusion sites of both derivative chromosomes from patient CB. (Top and bottom) genomic sequences of both wildtype parental genes; recombined derivative alleles are shown in the middle. Lower case letters: ALL-1 sequences (intron 11); capital letters: AF-4 sequences (intron3). Underlined sequences: duplicated upon translocation. Black dot: genomic fusion site `non-encoded' guanyl-nucleotides found in the der11 chromosome. Our scheme postulates that these were encoded by the`®ller' fragments f and g. These fragments would have been used to stabilize fragments A and J and the inverted fragment d'. In the der6 chromosome, single-strand fragment h would have to be inverted and fused on its 3'-side to fragment I, and on its 5'-side to fragment C via the single-strand fragment e.
The proposed`damage-repair mechanism' may not be restricted to translocations to the ALL-1 gene. Four published cases of bcr-abl translocations can also be explained by a similar mechanism (Litz et al., 1993; Zhang et al., 1995) . In these cases, duplication, inversion and deletion of DNA sequences most likely also occured. After reinterpretation of the published data we propose that the process for patient GM (Figure 7c ) is very similar to that presented above for the MV4;11 line, with the additional deletion of fragment B. Patient A (Figure 7a) shows duplications of two chromosomal segments similar to the t(4;11) translocation in patient CB (Figure 3d, Figure 4) , while patients AH and DM show the inversion of single- Figure 5 Comparison of the breakpoint structure in SEM cells and primary material from the same patient. Agarose gel loaded with PCR products generated with genomic DNA from SEM cells and primary biopsy material (pbm) of the same patient collected at the time of diagnosis. PCR reactions were performed using allele-speci®c sets of oligonucleotides for the wt11, der11, der4 and wt4 chromosomes, respectively. Marker: lambda phage DNA digested with ClaI. Neg: negative controls for each reaction. Sizes in basepairs (Figure 7b ) and the deletion of DNA fragments (Figure 7d) , respectively. In all of these published cases, duplications, inversions or deletions of short DNA fragments probably occured at the break sites ( Figure 6 ; Figure 7a ± d) and multiple single-strand or double-strand breaks need to be invoked to explain these translocations.
Discussion
Apparently, none of the translocations studied here occurred by simple reciprocal crossover events. Part of the original DNA sequences were either inverted, duplicated or deleted in all four t(4;11) lines under investigation, suggesting that the t(4;11) translocations studied here were reciprocal but not balanced at the ®ne-structure level.
This result was unexpected in view of current knowledge of other recombination events in mammalian cells. The characteristic features of a few wellknown recombinatorial mechanisms will be brie¯y summarized and compared with the new observations on t(4;11) translocations presented here. (1) Homologous recombination events such as sister chromatid exchange generally do not interfere with the stable propagation of the genome. There are no welldocumented reports of mutations as a direct result of these processes. (2) The somatic rearrangement of lymphocyte antigen receptor genes requires speci®c target sequences (heptamer-nonamer recognition sequences) and an enzymatic machinery that recognizes and digests these sequences, seals and nicks the DNA ends (P-nucleotides) and adds non-encoded DNA nucleotides (N-nucleotides) with the help of terminal deoxynucleotidyl transferase (Alt and Baltimore 1982; Tonegawa 1983 ). However, even this complex process that deletes extended stretches of genomic DNA between the ends of D and J or V and D regions, does not lead to duplications, deletions or inversions of short DNA sequences at the recombination site in a manner resembling that observed here at the translocation breakpoints. (3) Switch recombination of immunoglobulin heavy chain genes may lead to inversions or deletions. However, these comprise the entire fragment between the switch signals, which usually is many kilobasepairs in length. This is not comparable to the deletions and inversions of short DNA fragments observed here at the translocation breakpoints (Harriman et al., 1993) . (4) Integration of proviral cDNA or retrotransposons typically leads to small duplications of 2 ± 50 bp in the target DNA (socalled target site duplications) that¯ank both ends of the integrated DNA molecule. Depending on the type of retrovirus or retrotransposon, integration also leads to the deletion of a few terminal nucleotides of the proviral DNA. This process is mediated by enzymes encoded by the retrovirus or the retrotransposon, and is assisted by several host proteins (Varmus and Brown 1989; Con 1992) . (5) The illegitimate recombination process leading to the integration of transfected plasmid DNA into the recipient genome is mediated ®rst by a number of homologous recombination events among episomal plasmid molecules and only subsequently by an illegitimate recombination resulting in the integration. The latter process is normally accompanied by the deletion of a few nucleotides from the concatenate at the integration site (Murnane et al., 1990) .
The mechanism proposed here for t(4;11) translocations does not resemble any of these known mechanisms and it also clearly diers from other known translocations involving recombinases of the immune system (Rabbitts 1994) . For example, translocation t(7;11)(q35;p13) associated with an acute human T-cell leukemia (T-ALL) recombines the T-cell receptor (TCR) b locus with the rhombotin 2 gene (SanchezGarcia et al., 1991) . A detailed sequence analysis of the breakpoints of this translocation showed that it (a) was clearly reciprocal and balanced; and (b) involved recombinase signals, at least heptamer signals and possibly also nonamer signals. Another example is an inversion of chromosome 14 [inv(14;14)(q11;q32)] associated with human T-cell lymphomas (Baer et al., 1985 (Baer et al., , 1987 . In these cases, the TCRa locus recombined with the immunoglobulin heavy chain (IgH) locus creating a chimeric polypeptide designated IgT. In these cases too, signals for the RAG-recombinases of the immune system were unequivocally involved. These cases clearly dier from the translocations investigated in the present study, which are not balanced and show no evidence for the participation of site speci®c recombinases. For the translocations studied here the following characteristics are proposed.
Both chromosomes participating in the translocation process most likely underwent multiple breakages before the actual translocation occurred. The minimal requirement was one double-strand break on one chromosome and two single-strand breaks on the other (Figure 3a ; MV4;11). However, in most cases several single-strand breaks most likely occured before the actual translocation (Figure 3b ± d ; SEM, RS4;11, patient CB). We propose that t(4;11) translocations are initiated by several random DNA strand breaks and completed by a DNA repair process rather than being initiated by the action of sequence-speci®c recombinases. In those cases, in which staggered breaks were the initial event, the DNA located between the break sites was either duplicated (Figure 3a , fragments C and D; Figure 3d , fragments A-D) or deleted (Figure 3b , fragments B and E). Deletions can be created by either 3'-staggered breaks or two separate double-strand breaks. Here it is useful to recall that eukaryotic DNA polymerases can only repair 5'-protruding ends but neither 5'-recessed ends nor blunt end breaks. The more complicated inversions of fragment B observed in the der4 chromosome of RS4;11 cells (Figure 3c ) and the der11 chromosome of the LLM line are probably the result of single-strand breaks and basepairing of terminal nucleotides between the participating DNA fragments. Thus, DNA fragments released in the process most likely can be used as ®ller DNAs and may be recaptured by the subsequent repair and ligation process.
In several eukaryotic systems short oligonucleotides are used as`®ller' fragments to bridge DNA molecules during the repair process (Roth et al., 1991) . Such ®ller DNAs are single-stranded molecules of 2 ± 40 nucleotides that can be isolated from the nuclei of normal eukaryotic cells (Plesner et al., 1987) . In most cases the origin of these ®ller fragments is unknown. The novel observation made here was, that the ®ller fragments most likely were derived from the damaged chromosomal areas of the genes participating in the translocation.
A ®ller DNA fragment probably was used during the repair process generating the der4 chromosome in the SEM line. The 7 nucleotide fragment d most likely was derived from the 381 bp fragment B (Figure 3b) , which was lost except for this small fragment. Fragment d also provides an explanation for the origin of the additional guanyl residue found in the der4 chromosome of SEM cells. The central unpaired cytosine probably triggered a DNA repair process on the opposite strand. Another possible explanation for this additional residue invokes the action of terminal deoxynucleotidyl transferase. However, although the leukemic blasts express this gene (Greil et al., manuscript in preparation) , it is not known whether this enzyme was active at the time of the translocation.
Recently, another group also demonstrated the presence of short duplications and deletions in the chromosomal DNA of both derivative chromosomes from a patient and a cell line carrying translocation t(9;11) (Gill-Super et al., 1997) . These unusual characteristic features were found because these authors also analysed the breakpoints on both derivative chromosomes, der9 and der11, respectively. This observation is fully consistent with the`damagerepair model' proposed here for the t(4;11) translocation and others.
Therefore we propose that the initial event for a t(4;11) translocation and possibly for some of the other translocations discussed above most likely was a DNA damaging event. In spite of the importance of this problem, it is currently unknown, whether endogenous or exogenous agents or a combination of both are the major cause. In particular, there is no explanation for random breaks on both strands of both participating chromosomes. This type of event would occur with a very low probability based on simple statistical coincidence.
Two other central questions regarding translocations to the ALL-1 gene ask for: (a) the unusually tight local clustering of the breakpoints in this gene; and (b) the unusually large number of translocation partner genes. Both issues were recently discussed and reviewed Marschalek et al., 1997) . Brie¯y, two major explanations for the tight clustering were oered, one called the`hot-spot hypothesis', the other the`selection hypothesis'. The hot-spot hypothesis poses, that chromosomal breaks and translocations occur in the bcr-region of the ALL-1 gene with greater intrinsic frequency than in other chromosomal regions. This would have to be due to distinct properties of the DNA sequence and/or chromatin organization in this particular region. The selection hypothesis poses, that the original frequency of chromosomal breaks and rearrangements may be randomly distributed along the chromosomes. However, the reason why clustered breakpoints are observed in this speci®c area is, that only breaks occuring here will lead to a positively selectable advantage and clonal outgrowth of the corresponding leukemic blasts. Some recent evidence has accumulated in support of both hypotheses (Corral et al., 1996; Marschalek et al., 1997; Stanulla et al., 1997b; Slany et al., 1998) and currently the most attractive hypothesis appears to be that both mechanisms, which are not mutually exclusive, may contribute to the striking local clustering of the translocation breakpoints. The currently best explanation for the unusually large number of translocation partner loci is, that all of these partners may be able to convert an ALL-1 fragment by chimerization into novel oncogenic polypeptides. The promiscuity of the partner loci would therefore re¯ect an unsually large number of ways by which the ALL-1 protein can be converted into an oncogenic polypeptide.
One attractive hypothesis for the generation of recombination hot spots in the breakpoint cluster regions of the ALL-1 and AF-4 genes poses, that recombination among Alu-family repetitive elements occurs with elevated frequency in these regions . Indeed, for intra-chromosomal recombinations such as those generating internal duplications in chromosome 11 (Schichmann et al., 1994; So et al., 1997; Strout et al., 1998) the evidence is quite compelling. However, for inter-chromosomal translocations including t(4;11) translocations the evidence is far less convincing. Among the breakpoints studied here, the one in the MV4;11 line is located in an Alu-element on chromosome 11, but not on chromosome 4. Conversely, the breakpoint in the RS4;11 line is located at the 3'-end of an Alu-element on chromosome 4, but not on chromosome 11. None of the breakpoints studied here involve Alu-Alu recombinations. Additional preliminary data of 14 other t(4;11) translocations (Marschalek et al., unpublished data) show no evidence for Alu-Alu recombinations. Thus, we conclude that for inter-chromosomal translocations, Alu-Alu recombinations most likely play no major role.
Finally, it has been proposed that translocations to the ALL-1 gene can also be generated by treatment of cells or patients with topoisomerase II inhibitors (etoposides; Aplan et al., 1996; Stanulla et al., 1997a,b) . Indeed, a substancial body of published data reports that therapy-related secondary acute leukemias occuring in children and adults have translocations t(4;11), t(9;11) and others involving the ALL-1 gene (Pui et al., 1990b (Pui et al., , 1991b PedersenBjergaard 1992; Felix et al., 1993; Gill-Super et al., 1993) . Although it has not been formally proven, that treatment with topoisomerase II inhibitors was the direct cause of these translocations, the statistical correlation is suciently convincing, to make this a reasonable hypothesis. If topoisomerase II inhibitors were involved in the generation of translocations, then on the basis of mechanistic considerations we would expect to ®nd only 4 bp duplications but no deletions or inversions of several dozen to several hundred basepairs at the translocation breakpoints. In the two published cases indeed small 4 ± 5 bp duplications, but no deletions or inversions have been observed for the recombined ALL-1 sequences (Domer et al., 1995) . In addition, these breakpoints were clustered in a dierent subregion of the ALL-1 breakpoint cluster region than those reported here. Therefore, we propose, that the translocations associated with topoisomerase II inhibitors may have arisen by a mechanism diering from the DNA damage-repair mechanism proposed for the translocations presented here.
Materials and methods

Cell lines and cell culture
The leukemia-derived SEM and LLM cell lines were established in our own laboratory (Greil et al., 1994; Greil et al., manuscript in preparation) . All lines including the RS4;11 and MV4;11 lines were cultured as described (Gu et al., 1992a (Gu et al., ,b, 1994 Marschalek et al., 1995) .
Patient material
Biopsy material from patient SEM was collected at relapse. The same material was used for the establishment of the SEM line (Greil et al., 1994) . Biopsy material from patient CB was obtained at diagnosis. Patients SEM and CB were 5 yrs and 3 months old females, respectively. Both were treated at the Children's Hospital of the University of Erlangen-NuÈ rnberg and diagnosed to carry the t(4;11) translocation at the karyotypic and molecular level. White blood cell counts (WBC) at diagnosis were 492 000/ml for patient SEM and 686 000/ml for patient CB. Both had 99% blasts in their bone marrow and showed a poor response to therapy. Blasts from both patients had a pro-B cell immuno-phenotype (CD10 7 , CD19 + , Cm 7 , HLA-DR + ) and patient SEM was also CD13 + . Her blasts thus showed the mixed-lineage phenotype characteristic of t(4;11) leukemias at relapse (Greil et al., 1994) .
